Blastic Plasmacytoid Dendritic Cell Neoplasm

Preferred Label : Blastic Plasmacytoid Dendritic Cell Neoplasm;

MeSH definition : A rare and aggressive hematologic malignancy derived from the precursors of PLASMACYTOID DENDRITIC CELLS. Blastic plasmacytoid dendritic cell neoplasms affect bone marrow and blood in addition to the lymph nodes, spleen, central nervous system, and skin.;

MeSH synonym : Agranular CD4 CD56 Hematodermic Neoplasm-Tumor; Agranular CD4 CD56 Hematodermic Neoplasm Tumor; Agranular CD4 Natural Killer Cell Leukemia; Blastic Natural Killer Leukemia; Blastic Natural Killer Lymphoma; Blastic NK Cell Lymphoma; Blastic NK-Cell Lymphoma; Blastic NK-Cell Lymphomas; Lymphoma, Blastic NK-Cell; NK-Cell Lymphoma, Blastic; BPDCN; BPDCNs; CD4 -CD56 Hematodermic Neoplasm; CD4 CD56 Hematodermic Neoplasm; CD4 -CD56 Hematodermic Neoplasms; Hematodermic Neoplasm, CD4 -CD56 ; Hematodermic Neoplasms, CD4 -CD56 ; Neoplasm, CD4 -CD56 Hematodermic; Monomorphic NK-Cell Lymphoma; Lymphoma, Monomorphic NK-Cell; Monomorphic NK Cell Lymphoma; Monomorphic NK-Cell Lymphomas; NK-Cell Lymphoma, Monomorphic;

Details

Origin ID

D000099067;

UMLS CUI

C1301363;

Allowable qualifiers
- blood [MeSH Qualifier]
- blood supply [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemically induced [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- complications [MeSH Qualifier]
- congenital [MeSH Qualifier]
- diagnosis [MeSH Qualifier]
- diagnostic imaging [MeSH Qualifier]
- diet therapy [MeSH Qualifier]
- drug therapy [MeSH Qualifier]
- economics [MeSH Qualifier]
- embryology [MeSH Qualifier]
- enzymology [MeSH Qualifier]
- epidemiology [MeSH Qualifier]
- ethnology [MeSH Qualifier]
- etiology [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- mortality [MeSH Qualifier]
- nursing [MeSH Qualifier]
- parasitology [MeSH Qualifier]
- pathology [MeSH Qualifier]
- physiopathology [MeSH Qualifier]
- prevention and control [MeSH Qualifier]
- psychology [MeSH Qualifier]
- radiotherapy [MeSH Qualifier]
- rehabilitation [MeSH Qualifier]
- secondary [MeSH Qualifier]
- surgery [MeSH Qualifier]
- therapy [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
- veterinary [MeSH Qualifier]
- virology [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Blastic NK cell lymphoma [ICD-11 More detail]
Currated CISMeF NLP mapping
- Blastic NK-cell lymphoma [ICD-10 Sub-category]
- Blastic Plasmacytoid Dendritic Cell Neoplasm [NCIt concept]
- Blastic plasmacytoid dendritic cell neoplasm [ICD-11 More detail]
- Blastic plasmacytoid dendritic cell neoplasm (disorder) [SNOMED CT concept]
- CD4+/CD56+ hematodermic neoplasm [ORDO Disease]
Record concept(s)
- Blastic Plasmacytoid Dendritic Cell Neoplasm [MeSH concept]
See also inter- (CISMeF)
- Blastic plasmacytoid dendritic cell neoplasm (morphologic abnormality) [SNOMED CT concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Blastic NK-cell lymphoma [ICD-10 Sub-category]
- Blastic NK-cell lymphoma (morphologic abnormality) [Inactive SNOMED CT concept]
- Blastic Plasmacytoid Dendritic Cell Neoplasm [NCIt concept]
- Blastic plasmacytoid dendritic cell neoplasm [ICD-11 Subcategory]
- Blastic plasmacytoid dendritic cell neoplasm (disorder) [SNOMED CT concept]
- Blastic plasmacytoid dendritic cell neoplasm (morphologic abnormality) [SNOMED CT concept]
- blastic NK cell lymphoma [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients